Publications
67
Citations
397
Est. group size
~6
Recurring co-author estimate
Active years
22
Publishing since 2005
Dr. De Lima's research focuses on blood cancers such as acute myeloid leukemia, acute lymphoblastic leukemia, and multiple myeloma, with particular attention to hematopoietic stem cell transplantation (a procedure that replaces damaged bone marrow with healthy stem cells) and CAR-T cell therapy (an approach that reprograms a patient's immune cells to attack cancer). Much of the work involves clinical trials and large observational registries evaluating treatment safety, side effects like neurotoxicity and veno-occlusive disease, and outcomes after transplantation or cell therapy. This research is aimed at improving how patients with leukemia, lymphoma, and myeloma are treated before and after transplant or immunotherapy.
Publication output rose sharply around 2021-2022 but has slowed considerably in the most recent few years, averaging about 3.4 papers per year over the last five years.
Generated by claude-sonnet-5 from public bibliographic data · Jul 20, 2026
- Sinusoidal obstruction syndrome and other outcomes in pediatric patients with acute lymphoblastic leukemia who received inotuzumab ozogamicin before hematopoietic cell transplantation.
Journal of Clinical Oncology · 2025
- Assessment of Pretreatment and Posttreatment Evolution of Neurofilament Light Chain Levels in Patients Who Develop Immune Effector Cell–Associated Neurotoxicity Syndrome
JAMA Oncology · 2022
- Sequential Administration of Selinexor then CD19 CAR-T Cells Exhibits Enhanced Efficacy in a Mouse Model of Human Non-Hodgkin's Lymphoma
Blood · 2022
- Circulating Tumor DNA Correlation with Lymphoma Response and Survival Outcomes at Multiple Time Points of Anti - CD19 CAR T Cell Therapy
Blood · 2022
- Veno-Occlusive Disease Risk and Other Outcomes in Patients with B-Cell Precursor Acute Lymphoblastic Leukemia Who Received Inotuzumab Ozogamicin and Proceeded to Hematopoietic Stem Cell Transplantation: A Registry-Based, Observational Study
Blood · 2022
- Phase Ib trial of vactosertib in combination with pomalidomide in relapsed multiple myeloma: A corticosteroid-free approach by targeting TGF-β signaling pathway.
Journal of Clinical Oncology · 2021
- A registry-based, observational safety study of inotuzumab ozogamicin (InO) treatment in patients (pts) with B-cell precursor acute lymphoblastic leukemia (ALL) who proceeded to hematopoietic stem cell transplant (HSCT).
Journal of Clinical Oncology · 2021
- Sequential Single Cell Transcriptional and Protein Marker Profiling Reveals Tigit As a Marker of CD19 CAR-T Cell Dysfunction in Patients with Non-Hodgkin's Lymphoma
Blood · 2021
- Pre-Infusion Neurofilament Light Chain (NfL) Levels Predict the Development of Immune Effector Cell-Associated Neurotoxicity Syndrome (ICANS) - a Multicenter Retrospective Study
Blood · 2021
- Post-Transplant Inotuzumab Ozogamicin for Acute Lymphoblastic Leukemia
Blood · 2021
- <i>Prompt CR Plus Consolidation Therapy Yields Improve Survival after Allogeneic Transplantation for AML Patients Receiving Myeloablative, but Not Reduced-Intensity Conditioning: A CIBMTR Analysis</i>
Blood · 2021
- Final Results of a Phase 1 Study of AntiCD19 CAR-T Cells with TNFRSF19 Transmembrane Domain
Blood · 2021
- Next-Generation Sequencing to Assess the Impact of Low Dose Melphalan on Residual Disease before High-Dose Melphalan and Stem Cell Transplant in Multiple Myeloma
Blood · 2021
- Survival from time of transformation in patients with transformed lymphoma at time of diagnosis.
Journal of Clinical Oncology · 2020
- A highly effective and practical desensitization regimen: Results in comparable clinical outcomes for multiple myeloma patients with skin rash after immunomodulatory drugs.
Journal of Clinical Oncology · 2020
- Journal of Clinical Oncology×22
- Blood×19
- JAMA Oncology×2
- British Journal of Haematology×2
- medRxiv×2
- Karilyn Larkin
Medicine · The Ohio State University
- Gabriela Sanchez‐Petitto
Medicine · The Ohio State University
- Priyanka Mehta
Medicine · The Ohio State University
- Helee Desai
Medicine · The Ohio State University
- Sumithira Vasu
Medicine · The Ohio State University
This profile was generated automatically from public scholarly data (OpenAlex). Group size and activity levels are estimates derived from co-authorship patterns.
Last updated Jul 19, 2026.
Claim or correct this profile